Mapracorat ophthalmic formulation

mapracorat · Bausch & Lomb Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mapracorat ophthalmic formulation, covering 2020-09-04 to 2020-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis [Phase 2]